This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

This study has been completed.
Information provided by (Responsible Party):
Cook Group Incorporated Identifier:
First received: February 23, 2012
Last updated: January 19, 2017
Last verified: January 2017
The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.

Condition Intervention
Abdominal Aortic Aneurysm Aorto-iliac Aneurysm Device: Iliac Leg Graft

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

Resource links provided by NLM:

Further study details as provided by Cook Group Incorporated:

Primary Outcome Measures:
  • Assess short term and longer term outcomes, including outcomes related to patency, of the Zenith® Spiral-Z® AAA Iliac Leg Graft. [ Time Frame: 12 months ]

Enrollment: 600
Study Start Date: March 2012
Study Completion Date: March 2016
Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Abdominal aortic aneurysm Device: Iliac Leg Graft
Zenith® Spiral-Z® AAA Iliac Leg Graft


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients implanted with an FDA approved Zenith® Spiral-Z® AAA Iliac Leg Graft

Inclusion Criteria:

  • Patient is implanted with Zenith® Spiral-Z® AAA Iliac Leg Graft.

Exclusion Criteria:

  • Patients for whom this device would not normally be considered standard of care.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01540643

  Hide Study Locations
United States, Alabama
Valley Vascular Consultants
Huntsville, Alabama, United States, 35801
United States, Colorado
University of Colorado, Anschutz Medical Campus
Aurora, Colorado, United States, 80045
United States, Connecticut
Hartford Hospital
Hartford, Connecticut, United States, 06102
United States, Florida
University of Florida
Gainesville, Florida, United States, 32610
Mount Sinai Medical Center
Miami Beach, Florida, United States, 33140-2948
University of Miami Hospital
Miami, Florida, United States, 33136
United States, Georgia
University Hospital
Augusta, Georgia, United States, 30901
United States, Missouri
Missouri Heart Center
Columbia, Missouri, United States, 65201
Mercy Hospital Springfield
Springfield, Missouri, United States, 65804
United States, Montana
St. Vincent's Heart and Vascular Center
Billings, Montana, United States, 59101
United States, New Jersey
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Morristown Medical Center
Morristown, New Jersey, United States, 07960
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States, 08903
United States, New York
Albany Medical Center Hospital
Albany, New York, United States, 12208
Westchester Medical Center
Hawthorne, New York, United States, 10532
Mount Sinai Hospital
New York, New York, United States, 10029
United States, North Carolina
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States, 25157
United States, Ohio
Mount Carmel East
Columbus, Ohio, United States, 43213
United States, Oregon
Bend Memorial Clinic
Bend, Oregon, United States, 97701
United States, Pennsylvania
St. Luke's University Hospital
Bethlehem, Pennsylvania, United States, 18045
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15232
United States, Tennessee
Physican's Regional Medical Center
Knoxville, Tennessee, United States, 37909
United States, Texas
Houston VA
Houston, Texas, United States, 77030
United States, Utah
University of Utah Hospital
Salt Lake City, Utah, United States, 84132
United States, Washington
Providence Regional Medical Center Everett
Everett, Washington, United States, 98201
United States, West Virginia
Charleston Area Medical Center
Charleston, West Virginia, United States, 25304
United States, Wisconsin
Froedert Hospital
Milwaukee, Wisconsin, United States, 53226
Canada, Ontario
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L2X2
London Health Sciences Centre
London, Ontario, Canada, N6A 5W9
Ottawa Hospital Civic Campus
Ottawa, Ontario, Canada, K1Y 4E9
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4
Sponsors and Collaborators
Cook Group Incorporated
Principal Investigator: Thomas Lindsay Toronto General Hospital
  More Information

Responsible Party: Cook Group Incorporated Identifier: NCT01540643     History of Changes
Other Study ID Numbers: 11-015
Study First Received: February 23, 2012
Last Updated: January 19, 2017

Keywords provided by Cook Group Incorporated:
abdominal aortic aneurysm
iliac leg graft

Additional relevant MeSH terms:
Aortic Aneurysm
Aortic Aneurysm, Abdominal
Iliac Aneurysm
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases processed this record on September 19, 2017